|
| Monday, September 30, 2024 |
|
|
New Australian Issuing Certificate Authority Launched with SSLTrust: Verokey, for Australian Businesses, Government and the APAC Region |
| SSLTrust, a leading global provider of digital certificates for public key infrastructure, has identified the APAC region as needing a new local issuing Certificate Authority. more info >> |
|
| Saturday, September 28, 2024 |
|
|
Innovation Beverage Group Limited Announces Closing of $5.4 Million Initial Public Offering on the Nasdaq Capital Market Under Symbol "IBG" |
| The ordinary shares began trading on The Nasdaq Capital Market, under the symbols "IBG", on September 26, 2024. The Offering closed on September 27, 2024. more info >> |
|
| Friday, September 27, 2024 |
|
|
Excel Dryer Shines as a Double Honoree on Fast Company's Best Workplaces for Innovators List |
| Fast Company, the world's leading business media brand, with an editorial focus on innovation in technology, leadership, world-changing ideas, creativity and design, has selected Excel Dryer, Inc., for the 2024 100 Best Workplaces for Innovators (BWFI) list, ranking the manufacturer at number 40 among 100 companies that foster a culture of innovation and creativity in their workplaces worldwide. more info >> |
|
|
GA-ASI Adds NIDV and NATO DIANA to Blue Magic Netherlands Agenda |
| General Atomics Aeronautical Systems, Inc. (GA-ASI) has added Raymond Knops, Chairman of the Dutch Industry Foundation for Defence and Security (NIDV), and Thomas McSorley, General Counsel for NATO DIANA (Defence Innovation Accelerator for the North Atlantic), to a growing list of speakers and panelists on the agenda for the first-ever Blue Magic Netherlands (BMN) event being held on November 19, 2024. more info >> |
|
|
Get It While It's Cold: Cloud Retail Teams Up With Vilo Gelato to Ensure Frozen Gelato Deliveries Stay Perfectly Chilled |
| Delivering a temperature-sensitive product like gelato presents a number of challenges, especially in a tropical climate, so Vilo Gelato partnered with Cloud Retail to take advantage of its quick commerce experience. more info >> |
|
| Thursday, September 26, 2024 |
|
|
Cleverbridge Announces Payments Veteran Kevin Feagan as Chief Revenue Officer |
| Cleverbridge, the all-in-one e-commerce platform for global subscription businesses, today announced the appointment of Kevin Feagan as its Chief Revenue Officer. Feagan will report directly to Wendi Sturgis, Chief Executive Officer, and serve as a member of Cleverbridge's leadership team. more info >> |
|
|
Innovation Beverage Group Limited Announces Pricing of $5.4 Million Initial Public Offering on the Nasdaq Capital Market Under Symbol "IBG" |
| Innovation Beverage Group Limited ("IBG" or the "Company"), a developer, manufacturer, marketer, exporter and retailer of a growing beverage portfolio of 60 formulations across 13 alcoholic and non-alcoholic brands with a focus on premium and super premium brands, today announced the pricing of its initial public offering (the "Offering") of 1,350,000 ordinary shares, at a public offering price of $4.00 per share for total gross proceeds to the Company of $5.4 million, before deducting underwriting discounts and offering expenses. more info >> |
|
|
U.S. Polo Assn. Concludes the Successful European Polo Season |
| U.S. Polo Assn., the official brand of the United States Polo Association (USPA), proudly marked the successful conclusion of the European high-goal polo season, after sponsoring a series of prestigious tournaments across the continent. more info >> |
|
| Wednesday, September 25, 2024 |
|
|
SPACES: Digital Innovation Meets Contemporary Art at Phillips |
| HOFA Gallery and PhillipsX announce the launch of 'SPACES', the inaugural selling exhibition in HOFA's new curated digital realities series; which brings together leading voices in the intersection of technology and art. more info >> |
|
|
GEN Announces Positive Phase 2 Clinical Trial Results for GN-037 Topical Cream in Patients With Mild to Moderate Plaque Psoriasis |
| GEN Pharmaceuticals (GENIL.IS), a leading Turkish pharmaceutical company, has announced the positive results of its Phase 2 clinical trial evaluating the safety and efficacy of its investigational drug, GN-037 topical cream, in treating mild to moderate plaque psoriasis. more info >> |
|
|
|
|
